BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32601549)

  • 21. Multi-omics facilitated variable selection in Cox-regression model for cancer prognosis prediction.
    Liu C; Wang X; Genchev GZ; Lu H
    Methods; 2017 Jul; 124():100-107. PubMed ID: 28627406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative Evaluation of Machine Learning Models for Subtyping Triple-Negative Breast Cancer: A Deep Learning-Based Multi-Omics Data Integration Approach.
    Yang S; Wang Z; Wang C; Li C; Wang B
    J Cancer; 2024; 15(12):3943-3957. PubMed ID: 38911381
    [No Abstract]   [Full Text] [Related]  

  • 23. Survival prediction in patients with colon adenocarcinoma via multi-omics data integration using a deep learning algorithm.
    Lv J; Wang J; Shang X; Liu F; Guo S
    Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33258470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Supervised graph contrastive learning for cancer subtype identification through multi-omics data integration.
    Chen F; Peng W; Dai W; Wei S; Fu X; Liu L; Liu L
    Health Inf Sci Syst; 2024 Dec; 12(1):12. PubMed ID: 38404715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrating multi-omics data through deep learning for accurate cancer prognosis prediction.
    Chai H; Zhou X; Zhang Z; Rao J; Zhao H; Yang Y
    Comput Biol Med; 2021 Jul; 134():104481. PubMed ID: 33989895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A hierarchical integration deep flexible neural forest framework for cancer subtype classification by integrating multi-omics data.
    Xu J; Wu P; Chen Y; Meng Q; Dawood H; Dawood H
    BMC Bioinformatics; 2019 Oct; 20(1):527. PubMed ID: 31660856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of cancer risk groups through multi-omics integration using autoencoder and tensor analysis.
    Braytee A; He S; Tang S; Sun Y; Jiang X; Yu X; Khatri I; Chaturvedi K; Prasad M; Anaissi A
    Sci Rep; 2024 May; 14(1):11263. PubMed ID: 38760420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histopathological Images and Multi-Omics Integration Predict Molecular Characteristics and Survival in Lung Adenocarcinoma.
    Chen L; Zeng H; Xiang Y; Huang Y; Luo Y; Ma X
    Front Cell Dev Biol; 2021; 9():720110. PubMed ID: 34708036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating DNA Methylation, Gene Expression, Somatic Mutation, and Their Combinations in Inferring Tumor Tissue-of-Origin.
    Liu H; Qiu C; Wang B; Bing P; Tian G; Zhang X; Ma J; He B; Yang J
    Front Cell Dev Biol; 2021; 9():619330. PubMed ID: 34012960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incorporating inter-relationships between different levels of genomic data into cancer clinical outcome prediction.
    Kim D; Shin H; Sohn KA; Verma A; Ritchie MD; Kim JH
    Methods; 2014 Jun; 67(3):344-53. PubMed ID: 24561168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BRCA-Pathway: a structural integration and visualization system of TCGA breast cancer data on KEGG pathways.
    Kim I; Choi S; Kim S
    BMC Bioinformatics; 2018 Feb; 19(Suppl 1):42. PubMed ID: 29504910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Group Lasso Regularized Deep Learning for Cancer Prognosis from Multi-Omics and Clinical Features.
    Xie G; Dong C; Kong Y; Zhong JF; Li M; Wang K
    Genes (Basel); 2019 Mar; 10(3):. PubMed ID: 30901858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of miRNA-Mediated Subpathways as Prostate Cancer Biomarkers Based on Topological Inference in a Machine Learning Process Using Integrated Gene and miRNA Expression Data.
    Ning Z; Yu S; Zhao Y; Sun X; Wu H; Yu X
    Front Genet; 2021; 12():656526. PubMed ID: 33841512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Capsule Network Based Modeling of Multi-omics Data for Discovery of Breast Cancer-Related Genes.
    Peng C; Zheng Y; Huang DS
    IEEE/ACM Trans Comput Biol Bioinform; 2020; 17(5):1605-1612. PubMed ID: 30969931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics data.
    Xu Y; Dong Q; Li F; Xu Y; Hu C; Wang J; Shang D; Zheng X; Yang H; Zhang C; Shao M; Meng M; Xiong Z; Li X; Zhang Y
    J Transl Med; 2019 Aug; 17(1):255. PubMed ID: 31387579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrated genomic analysis for prediction of survival for patients with liver cancer using The Cancer Genome Atlas.
    Song YZ; Li X; Li W; Wang Z; Li K; Xie FL; Zhang F
    World J Gastroenterol; 2018 Jul; 24(28):3145-3154. PubMed ID: 30065560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic classification of cancers using extreme gradient boosting algorithm and multi-omics data.
    Ma B; Meng F; Yan G; Yan H; Chai B; Song F
    Comput Biol Med; 2020 Jun; 121():103761. PubMed ID: 32339094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attention-based GCN integrates multi-omics data for breast cancer subtype classification and patient-specific gene marker identification.
    Guo H; Lv X; Li Y; Li M
    Brief Funct Genomics; 2023 Nov; 22(5):463-474. PubMed ID: 37114942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NCC-AUC: an AUC optimization method to identify multi-biomarker panel for cancer prognosis from genomic and clinical data.
    Zou M; Liu Z; Zhang XS; Wang Y
    Bioinformatics; 2015 Oct; 31(20):3330-8. PubMed ID: 26092859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. -Omics biomarker identification pipeline for translational medicine.
    Bravo-Merodio L; Williams JA; Gkoutos GV; Acharjee A
    J Transl Med; 2019 May; 17(1):155. PubMed ID: 31088492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.